ApothéCure Recalls Compounded Products Due to Sterility Concerns

En Español

Over the past few months, the U.S. Food and Drug Administration has released several warnings of unsafe products related to sterility assurance concerns. Along with MedPrep, Clinical Specialties, and NuVision, compounding company ApothéCure now faces similar disputes. On April 15, 2013, ApothéCure issued a recall of all sterilized products that had been compounded through the company.

Recalled Products

ApothéCure has faxed users a notification of the recall including information of the specific medications recalled. According to the corporation, products involved in the recall consist of injections in vials containing a label that reads “Independently tested for sterility”. For more questions or to check if you have a product that was involved in the recall, contact ApothéCure by:

• calling (800)969-6601 or (972)960-6601
• emailing [email protected]

Reporting Adverse Events and Recalled Products

While no adverse reactions have been reported, ApothéCure advises consumers to terminate therapies with recalled products and return the medications. Patients should contact  their healthcare provider as a further precaution. Consumers who have had serious side effects should inform officials through the U.S. Food and Drug Administration MedWatch Adverse Event Reporting Program. Information on how to file a report to the FDA may be found here.

Don’t become the victim of a recalled product; stay informed by reading more at bad-drug.net.